StockPriceToday
CorVel Corp. (CRVL)
About CorVel Corp.
CorVel Corp. was founded in 1987 and has grown to become a prominent provider of workers' compensation administration and managed care services in the United States. The company combines proprietary technology platforms with clinical expertise to help employers, insurance carriers, and third-party administrators manage workers' compensation claims more effectively and control medical costs. CorVel's integrated approach includes case management, bill review, preferred provider networks, and specialized clinical programs that help injured workers return to productivity while containing claim costs. Healthcare cost inflation, workers' compensation regulations, and employment trends significantly influence CRVL stock price as investors evaluate the company's performance in the specialized healthcare services market.
The company is led by CEO Michael Combs, who has extensive experience in healthcare services and workers' compensation management, having guided CorVel through sustained growth and technological advancement. The management team emphasizes innovation, clinical excellence, and operational efficiency to maintain competitive advantages in the workers' compensation services market. Their strategic focus on technology development, data analytics, and outcome-based programs has helped establish CorVel as a leader in medical cost containment and case management solutions. These leadership capabilities and strategic initiatives directly impact investor confidence and CRVL stock price performance as the company competes in the healthcare services sector.
CorVel operates through multiple service lines including workers' compensation administration, managed care services, and specialized clinical programs, generating revenue through service fees and performance-based contracts with employers, insurance carriers, and government agencies. The company's proprietary technology platforms and clinical programs help clients achieve better outcomes while controlling costs in workers' compensation claims management. With the ongoing focus on healthcare cost containment and the need for specialized workers' compensation expertise, CorVel's services remain in demand across different economic conditions. For investors, understanding workers' compensation market dynamics, healthcare cost trends, and regulatory changes is important when evaluating the company's growth prospects and factors affecting stock price performance in the healthcare services sector.
CRVL Stock 12 Month Chart
Latest News for CRVL
The chief information officer of Cervel reported selling 2,400 shares for a total of $130,000, based on a weighted average price of $54.00 per share on March 16, 2026. The entire transaction involved ...
CorVel Corporation remains under pressure despite strong Q2 results, with revenues up 7% and net profit up 19% year-over-year. CRVL faces headwinds from a shortage of qualified professionals and rapid ...
CorVel remains an exceptional, debt-free company with strong free cash flow and consistent revenue growth, but recent earnings misses have shifted sentiment. Despite ongoing AI investments and robust ...
Other Popular Stocks
Immunovant Inc. (IMVT) is a biotechnology company developing immunology therapies for autoimmune diseases using antibody and protein engineering approaches.
Fortrea Holdings Inc. (FTRE) is a contract research organization providing clinical development and commercialization services to biopharmaceutical companies worldwide.
Urban Outfitters Inc. (URBN) is a leading lifestyle retailer operating Urban Outfitters, Anthropologie, and Free People brands, targeting young adults and creative individuals with...